Inventor · disambiguated record
Jakob Dupont
Also filed as: DUPONT JAKOB
9 granted patents·21 pending applications·29 citations·filing 2004–2024
85Inventor score
Top patents by PatentIndex Score
30 records- 0189US9599620B2Methods and monitoring of treatment with a DLL4 antagonistONCOMED PHARM INC·Filed 2013·Granted Mar 21, 2017·7 cites·21 claims
- 0283US9359444B2Methods and monitoring of treatment with a Wnt pathway inhibitorONCOMED PHARM INC·Filed 2014·Granted Jun 7, 2016·6 cites·29 claims
- 0383US9266959B2Methods of treating neuroendocrine tumors using frizzled-binding agentsONCOMED PHARM INC·Filed 2013·Granted Feb 23, 2016·6 cites·20 claims
- 0481US11136384B2Methods for treatment of cancer comprising TIGIT-binding agentsMEREO BIOPHARMA 5 INC·Filed 2020·Granted Oct 5, 2021·1 cites·30 claims
- 0581US2025177522A1Anti-angiogenesis therapy for the treatment of ovarian cancerGENENTECH INC·Filed 2024·Application pending·0 cites
- 0680US11046760B2Combination therapy for treatment of diseaseONCOMED PHARM INC·Filed 2018·Granted Jun 29, 2021·2 cites·19 claims
- 0778US11339213B2Methods and compositions for treatment of cancerMEREO BIOPHARMA 5 INC·Filed 2016·Granted May 24, 2022·2 cites·36 claims
- 0877US2025179169A1Combination therapy for treatment of diseaseMEREO BIOPHARMA 5 INC·Filed 2024·Application pending·0 cites
- 0974US11230596B2Methods for treatment of cancer comprising TIGIT-binding agentsMEREO BIOPHARMA 5 INC·Filed 2017·Granted Jan 25, 2022·1 cites·13 claims
- 1074US2023226179A1Anti-angiogenesis therapy for the treatment of ovarian cancerGENENTECH INC·Filed 2023·Application pending·0 cites
- 1168US8778340B2Anti-angiogenesis therapy for the treatment of ovarian cancerDUPONT JAKOB·Filed 2011·Granted Jul 15, 2014·4 cites·10 claims
- 1267US2022340653A1Methods for treatment of cancer comprising tigit-binding agentsMEREO BIOPHARMA 5 INC·Filed 2021·Application pending·0 cites
- 1366US2021403553A1Combination therapy for treatment of diseaseONCOMED PHARM INC·Filed 2021·Application pending·0 cites
- 1461US2021052728A1Anti-angiogenesis therapy for the treatment of ovarian cancerGENENTECH INC·Filed 2020·Application pending·0 cites
- 1559US2017299598A1Methods and Monitoring of Treatment With A DLL4 AntagonistONCOMED PHARM INC·Filed 2017·Application pending·0 cites
- 1657US2018344847A1Anti-angiogenesis therapy for the treatment of ovarian cancerGENENTECH INC·Filed 2018·Application pending·0 cites
- 1757US2016334423A1Methods and monitoring of treatment with a dll4 antagonistONCOMED PHARM INC·Filed 2016·Application pending·0 cites
- 1855US9987357B2Methods and monitoring of treatment with a WNT pathway inhibitorONCOMED PHARM INC·Filed 2016·Granted Jun 5, 2018·0 cites·20 claims
- 1954US2019000970A1Methods and Monitoring of Treatment with a WNT Pathway InhibitorONCOMED PHARM INC·Filed 2018·Application pending·0 cites
- 2053US2017143826A1Anti-angiogenesis therapy for the treatment of ovarian cancerGENENTECH INC·Filed 2017·Application pending·0 cites
- 2151US2016279241A1Anti-angiogenesis therapy for the treatment of ovarian cancerGENENTECH INC·Filed 2016·Application pending·0 cites
- 2251US2016176962A1Combination Therapy For Treatment Of DiseaseONCOMED PHARM INC·Filed 2015·Application pending·0 cites
- 2350US2014178371A1Anti-angiogenesis therapy for the treatment of ovarian cancerDUPONT JAKOB·Filed 2014·Application pending·0 cites
- 2445US2007269831A1Method for Early Detection of Ovarian CancerSLOAN KETTERING INST CANCER·Filed 2004·Application pending·0 cites
- 2543US2013323266A1Methods for treating cancer with notch2/3 antibodiesONCOMED PHARM INC·Filed 2013·Application pending·0 cites
- 2642US2016235844A1Methods of treating neuroendocrine tumors using frizzled-binding agentsONCOMED PHARM INC·Filed 2016·Application pending·0 cites
- 2741US2015232570A1Methods of Treating Hematological Malignancies with Notch1 AntibodiesONCOMED PHARM INC·Filed 2013·Application pending·0 cites
- 2836US2005281822A1Method of administering and using VEGF inhibitors for the treatment of malignant pleural effusionCEDARBAUM JESSE M·Filed 2005·Application pending·0 cites
- 2932US2017022289A1Methods for treating cancer with notch1 antiboidesONCOMED PHARM INC·Filed 2015·Application pending·0 cites
- 3031US2017157245A1Treatment of gastric cancerONCOMED PHARMACEUTLCALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jakob Dupont files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →